Related Experiment Videos
Pathophysiology of sickle cell disease.
1VA Medical Center, Jackson, Mississippi 39216, USA.
Bailliere'S Clinical Haematology
|June 29, 2000
Summary
Sickle cell disease stems from a beta-globin mutation, causing abnormal haemoglobin polymerization. Disease severity varies due to secondary genetic factors and acquired cell damage, impacting tissue perfusion.
Area of Science:
- Hematology
- Genetics
- Pathophysiology
Background:
- Sickle cell disease (SCD) originates from a mutation in the beta-globin gene, leading to abnormal hemoglobin (HbS).
- HbS polymerizes upon deoxygenation, causing red blood cells to sickle.
- The precise mechanisms by which sickled cells impede normal tissue perfusion remain incompletely understood.
Purpose of the Study:
- To explore the complex pathophysiology of sickle cell disease.
- To investigate factors contributing to variable disease severity in patients with sickle cell anemia.
Main Methods:
- This abstract does not detail specific methods.
- The study focuses on the molecular basis and contributing factors to sickle cell disease.
Main Results:
- Sickle haemoglobin polymerizes when deoxygenated.
- Despite identical primary mutations, patient disease manifestation varies significantly.
- Secondary genetic factors and acquired cellular damage are implicated in disease pathophysiology.
Conclusions:
- The pathophysiology of sickle cell disease is multifactorial.
- Understanding secondary genetic determinants and acquired damage is crucial for explaining disease variability.